Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

MOTS-c

A remarkable 16-amino-acid peptide encoded by your mitochondrial DNA that acts as an 'exercise mimetic'—boosting metabolism, improving insulin sensitivity, and helping your cells adapt to metabolic stress just like a good workout would [1][3].

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

MetabolicResearch compound

Suggested dose

5 – 10 mg

Once dailyCycle: 4-6 weeksOnset: Moderate (1-2 weeks)
Approximately 4-8 hoursHalf-life(estimated from preclinical data)
High when injected subcutaneouslyBioavailability
2174.64 g/molMolecular weight
Strong preclinicalEvidence level

Compound profile

MOTS-c scientific & efficacy data

Metabolic

Peptide profile

Metabolic Enhancement9.5
Insulin Sensitivity9.2
Mitochondrial Function9.0

Strong preclinical

MOTS-c

5 mg · Once daily

Molecular formula

C101H152N28O22S2

Mol. weight
2174.64 g/mol
CAS number
1627580-64-6
PubChem
121307043
Developed · 2015
Changhan Lee, PhD and Pinchas Cohen, MD
University of Southern California Leonard Davis School of Gerontology

Amino acid sequence

Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR)

Metabolic Enhancement

Directly activates AMPK and improves glucose metabolism through multiple validated pathways, making it one of the most potent metabolic peptides discovered

Insulin Sensitivity

Significantly improves how muscle cells respond to insulin, enhancing glucose uptake and reducing insulin resistance in extensive preclinical research [1][2][4]

Mitochondrial Function

Optimizes mitochondrial bioenergetics, increases efficiency, and reduces oxidative stress—supporting cellular energy production at its source [5]

Dosing

How much MOTS-c do I take?

5 – 10 mg · 2-3 times per week

5 – 10 mg

2-3 times per week

Covers all 2 documented dose levels · timing · dose-adjustment guidance.

Every documented dose level

PhaseDoseFrequency
4-week cycle5 mg2-3 times per week
Weeks 4-810 mg2-3 times per week
MOTS-c2-3 times per week

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Suitability

Is MOTS-c right for me?

Best for metabolic health optimization & insulin sensitivity improvement

Best for

Metabolic Health Optimizers

If you're looking to improve how your body handles glucose and energy, MOTS-c directly targets these systems [1]. It's like giving your cells a metabolic tune-up, helping them respond better to insulin and process sugar more efficiently—key factors for long-term health.

Those Seeking Exercise-Like Benefits

Nicknamed an 'exercise mimetic,' MOTS-c activates many of the same pathways that get turned on during physical activity [1][3]. While it's not a replacement for actual exercise, it may help enhance the benefits you get from working out or provide some metabolic support when exercise is limited.

Weight Management Seekers

Animal studies show impressive prevention of diet-induced obesity [1]. While human data is still emerging, MOTS-c's effects on fat metabolism and insulin sensitivity suggest potential benefits for those working on healthy weight management alongside diet and exercise [2].

Healthy Aging Enthusiasts

MOTS-c levels naturally decline with age, which may contribute to age-related metabolic problems [7]. Supplementing may help restore more youthful metabolic function, supporting the body's ability to regulate energy and maintain muscle mass as we get older [4].

Consider alternatives if

Metabolic enhancement through different mechanismsSemaglutide (GLP-1 agonist), Tirzepatide, AOD-9604
AMPK activation through supplementsBerberine, Metformin, AICAR
Mitochondrial support without peptidesNAD+ precursors (NMN, NR), CoQ10, PQQ, Alpha-lipoic acid

Do not use if

You are pregnant or might become pregnant—effects on fetal development are unknownYou are breastfeeding—the peptide could potentially pass into breast milkYou have active cancer or a history of cancer—metabolic manipulation in cancer cells is complexYou've ever had a serious allergic reaction to any peptideYou're under 18—MOTS-c is for adult use only in research settingsYou have severe hypoglycemia issues—MOTS-c may further lower blood glucose

Use with caution if

You take diabetes medications—MOTS-c improves insulin sensitivity, which could cause low blood sugarYou have liver or kidney disease—clearance of the peptide may be affectedYou're on other metabolic-affecting medications—potential for interactionsYou have a history of eating disorders—metabolic effects should be carefully monitoredYou take blood pressure medications—metabolic changes may affect BP

Not sure?

Compare MOTS-c with similar peptides to find the best fit for your goals.

Administration

How do I use MOTS-c?

Subcutaneous injection · Intramuscular injection

Route

Subcutaneous injection (just under the skin)—the easiest and most common method for self-administration

Best sites

Belly fat area (about 2 inches away from your belly button)Front or outer thigh (middle section)Back of the upper arm (have someone help if needed)

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is MOTS-c safe?

3 common side effects · 1 serious

MOTS-c has shown an excellent safety profile in preclinical studies, with extensive animal research demonstrating beneficial effects without significant adverse events [8].

The peptide is naturally produced by your own mitochondria, which suggests inherent compatibility with human biology [1]. However, human clinical trial data is still limited, so caution is warranted. Most reported experiences involve minimal side effects, primarily mild injection site reactions.

Most safety and efficacy data comes from well-designed animal studies conducted by Dr. Pinchas Cohen's team at USC and collaborating researchers worldwide [1][2]. Human data is emerging from ongoing research but remains limited. Always work with a healthcare provider when using research compounds.

Less common

Changes in appetiteMild hypoglycemia symptoms

These typically resolve with continued use or dose adjustment.

Common side effects · experienced by some users

  • Injection site redness

    A little pink or red area where you injected is totally normal. It's just your skin reacting to the needle and solution.

    Management: Rotate injection sites between belly, thigh, and arm. A cool compress can help. Usually fades within 24-48 hours.

  • Mild fatigue

    Some users report feeling slightly tired in the first few days, possibly as the body adjusts to enhanced metabolic activity.

    Management: This typically resolves within 3-5 days. If persistent, consider reducing your dose. Ensure adequate sleep and hydration.

  • Mild headache

    Occasional headaches may occur as your metabolism adjusts, similar to what some people experience when starting new exercise routines.

    Management: Stay well-hydrated and rest if needed. These typically resolve within the first week.

Stop and seek help if

  • Any signs of allergic reaction—stop immediately and seek medical help
  • Persistent fatigue that doesn't improve after the first week
  • Recurrent hypoglycemia symptoms, especially if you're diabetic
  • Injection site reactions that spread or don't heal
  • Any side effect that feels serious or really concerns you
  • Your research protocol/cycle is complete

MOTS-c is a research compound, not an FDA-approved medication. Never start, stop, or change your dosing without guidance from a qualified healthcare provider. This information is for educational purposes only—not medical advice.

With other peptides

  • Safe:Epithalon — Excellent pairing for comprehensive anti-aging support. Epithalon works on telomeres while MOTS-c optimizes metabolism. Inject at different sites.
  • Safe:BPC-157 — Safe to combine. BPC-157 focuses on healing and gut health, complementing MOTS-c's metabolic effects.
  • Safe:GHK-Cu — Can be used together for multi-targeted aging support. Different mechanisms with no known conflicts.
  • Safe:Semaglutide — Both affect glucose metabolism. If combining, monitor blood sugar very carefully for potential hypoglycemia.

With medications

  • Caution:Insulin — MOTS-c improves insulin sensitivity, which could significantly increase hypoglycemia risk. Reduce insulin dose and monitor closely with your doctor.
  • Caution:Sulfonylureas (glyburide, glipizide) — Both lower blood sugar—increased hypoglycemia risk. Consult your doctor before combining.
  • Safe:Metformin — Both activate AMPK. May have synergistic effects. Start with lower doses and monitor glucose.
  • Safe:Blood pressure medications — Metabolic changes may affect blood pressure. Monitor and inform your doctor.

With supplements

  • Safe:Berberine — Both activate AMPK. Potential for enhanced effects on glucose metabolism. Monitor blood sugar if using together.
  • Safe:NAD+ precursors (NMN, NR) — Complementary mechanisms for mitochondrial health. Safe to combine for enhanced cellular energy support.
  • Safe:CoQ10 — Supports mitochondrial function alongside MOTS-c. Safe and potentially synergistic.
  • Safe:Alpha-lipoic acid — Both affect glucose metabolism. Monitor blood sugar if taking high doses together.

Effectiveness

How do I know MOTS-c is working?

Strong preclinical · first signs days 1-7

Evidence level

Strong preclinical

(extensive animal studies)

70/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)

How it works

Your mitochondria—the tiny power plants inside every cell—don't just produce energy.

They also send out signaling molecules that tell the rest of your body how your energy systems are doing [1][2]. MOTS-c is one of these signals, a 16-amino-acid messenger that travels through your bloodstream to your muscles and other tissues [1].

When it arrives, it flips on a master switch called AMPK that normally gets activated during exercise [1][3]. This triggers your cells to take in more glucose, burn more fat, and work more efficiently [1][2]. It's like your mitochondria are texting your muscles: 'Hey, let's get in shape!'

The result? Better metabolism, improved insulin sensitivity, and protection against the metabolic decline that comes with aging [1][2].

The deeper mechanism

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded by a short open reading frame within the mitochondrial 12S rRNA gene [1]. Upon translation, MOTS-c is secreted and acts as an endocrine factor, primarily targeting skeletal muscle [1].

Its mechanism involves inhibition of the folate-methionine cycle through suppression of de novo purine biosynthesis, leading to accumulation of the endogenous AMPK activator AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) [2].

Activated AMPK then phosphorylates downstream targets including PGC-1α, enhancing mitochondrial biogenesis, oxidative phosphorylation efficiency, and glucose transporter (GLUT4) translocation to the cell membrane [3][5].

MOTS-c also directly binds and activates casein kinase 2 (CK2) in muscle tissue, which is required for its anti-atrophic and glucose-uptake enhancing effects [4].

Additionally, MOTS-c translocates to the nucleus under metabolic stress conditions, where it regulates ARE-containing genes and enhances cellular stress adaptation through Nrf2 pathway modulation [6].

This multi-modal mechanism explains its broad metabolic effects spanning glucose homeostasis, lipid metabolism, and mitochondrial function.

What to expect

  1. Days 1-7

    What you might notice

    • Mild injection site redness (totally normal)
    • Possibly some initial fatigue as your metabolism adjusts
    • Maybe nothing obvious yet—MOTS-c works at the cellular level
    • Some users report subtle energy changes

    What's normal

    • Minor injection site reactions that fade within a day
    • Feeling your body adapt to new metabolic signaling
    • No dramatic changes yet—this is cellular-level optimization

    What's next

    • Keep following your protocol consistently
    • Track how you feel during workouts if exercising
    • Side effects typically improve after day 3-5
  2. Weeks 2-3

    What you might notice

    • Improved energy levels, especially during physical activity
    • Potentially better workout performance or recovery
    • More stable energy throughout the day (fewer crashes)
    • Some users notice improved body composition starting

    What's normal

    • Settling into the routine with fewer side effects
    • Metabolic improvements becoming noticeable
    • Blood glucose more stable if you're monitoring

    What's next

    • Continue your cycle as planned
    • Consider adding complementary supplements if desired
    • Track any changes in body composition or exercise performance
  3. Weeks 4-6

    What you might notice

    • Fuller metabolic benefits becoming apparent
    • Improved insulin sensitivity if measured
    • Better body composition with consistent diet and exercise
    • Enhanced exercise capacity and recovery

    What's normal

    • Stable, sustained improvements in metabolic markers
    • Benefits plateau as you approach cycle end
    • Feeling generally more metabolically resilient

    What's next

    • Complete your cycle as planned
    • Take a 2-4 week break before next cycle
    • Benefits often persist for weeks after stopping

Signs it's working

Energy and Performance

  • More stable energy levels throughout the day
  • Better exercise performance or endurance
  • Improved workout recovery
  • Less post-meal energy crashes
  • Enhanced mental clarity during physical activity

Metabolic Markers (if testing)

  • Improved fasting glucose levels
  • Better HbA1c readings over time
  • Improved insulin sensitivity on testing
  • More favorable lipid panel results
  • Reduced inflammatory markers

Body Composition

  • Gradual improvements in body composition
  • Reduced stubborn fat with consistent diet
  • Maintained or improved muscle mass
  • Better response to exercise for fat loss

Not seeing results? Common reasons

  • Expecting immediate dramatic results—MOTS-c works gradually over weeks, not days
  • Not combining with appropriate diet and exercise—MOTS-c enhances metabolic function but isn't a magic bullet
  • Poor quality peptide from unreliable source—always get third-party testing certificates (COAs)
  • Improper storage degraded the peptide—check if your solution looks clear before using
  • Inconsistent dosing schedule—daily consistency is key for optimal results
  • Unrealistic expectations—MOTS-c supports metabolic health but won't replace lifestyle factors

Key research

2015[1]
“The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance”Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen PFinding: This groundbreaking discovery paper identified MOTS-c as a new hormone encoded in mitochondrial DNA. The researchers showed that MOTS-c targets skeletal muscle, activates AMPK, and prevents both age-dependent and diet-induced insulin resistance and obesity in mice—establishing it as a genuine metabolic regulator.View study
2016[2]
“MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism”Lee C, Kim KH, Cohen PFinding: This review confirmed MOTS-c's role as a 'mitochondrial hormone' with far-reaching effects. It explained how MOTS-c inhibits the folate cycle and purine biosynthesis, leading to AMPK activation—making it a potential therapeutic target for obesity, diabetes, and aging-related metabolic decline.View study
2024[3]
“Endurance training enhances skeletal muscle mitochondrial respiration by promoting MOTS-c secretion”Feng Y, Rao Z, Tian X, Hu Y, Yue L, Meng Y, Zhong Q, Chen W, Xu W, Li H, Hu Y, Shi RFinding: This study in marathon runners and mice revealed that MOTS-c levels closely correlate with aerobic exercise capacity. Endurance training boosts MOTS-c secretion, which enhances mitochondrial function through AMPK/PGC-1α activation—suggesting MOTS-c mediates some of exercise's metabolic benefits.View study
2024[4]
“MOTS-c modulates skeletal muscle function by directly binding and activating CK2”Kumagai H, Kim SJ, Miller B, et al.Finding: Researchers discovered that MOTS-c directly binds and activates the CK2 enzyme, which is required for its muscle-protective effects. The study also found that a natural MOTS-c variant (K14Q) with reduced CK2 binding is associated with higher sarcopenia and type 2 diabetes risk—providing the first genetic link between MOTS-c and human metabolic disease.View study
2026[5]
“MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner”Gudiksen A, Hansen CC, van der Stede T, et al.Finding: This study demonstrated that MOTS-c administration improves mitochondrial bioenergetic performance in skeletal muscle through PGC-1α and AMPK pathways. Importantly, it reduced mitochondrial reactive oxygen species and oxidative damage, showing MOTS-c protects cells from the harmful byproducts of energy production.View study
2018[6]
“The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress”Kim KH, Son JM, Benayoun BA, Lee CFinding: In cultured cells, MOTS-c moved from the mitochondria into the nucleus within about 30 minutes of metabolic stress such as glucose restriction, serum removal, or oxidative stress, and this movement depended on AMPK. Once in the nucleus, MOTS-c bound antioxidant response element (ARE) sequences in genes including HO-1 and NQO1 and interacted with the stress-response transcription factor NRF2, increasing expression of those genes.View study
2020[7]
“Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition”D'Souza RF, Woodhead JST, Hedges CP, Zeng N, Wan J, Kumagai H, Lee C, Cohen P, Cameron-Smith D, Mitchell CJ, Merry TLFinding: In healthy men, circulating MOTS-c was 11% lower in middle-aged men (45-55 y) and 21% lower in older men (70-81 y) than in young men (18-30 y), and the age effect remained statistically significant after adjusting for body composition and metabolic measures. Skeletal muscle MOTS-c moved in the opposite direction, being roughly 1.5-fold higher in the older groups, and plasma MOTS-c was not correlated with HOMA-IR.View study
2024[8]
“MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis”Yang L, Li M, Liu Y, Bai Y, Yin T, Chen Y, Jiang J, Liu SFinding: Alongside its main findings on pain behaviour, this mouse study assessed organ safety after long-term intraperitoneal MOTS-c dosing. Chronic administration had little effect on liver, renal, lipid, or cardiac function measures, and no differences in histological damage to liver, spleen, or kidney were seen between treated and control groups.View study
2021[9]
“Cellular and Molecular Mechanisms of Metformin Action”LaMoia TE, Shulman GIFinding: This review states that metformin's glucose-lowering effect in people with poorly controlled type 2 diabetes comes primarily from inhibiting hepatic glucose production, and reviews the clinical studies in patients that confirmed this. It also traces metformin's clinical history from its 1957 introduction by Jean Sterne through FDA approval in 1994.View study
2026[10]
“FDA Evaluation of MOTS-c-Related Bulk Drug Substances (MOTS-c (free base) and MOTS-c acetate) — FDA Briefing Document, Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026”U.S. Food and Drug Administration, CDER (Li J, Poon N-L, Asante K, Albuquerque E, Benedict A, San Antonio M, Kasim S)Finding: FDA review (dated 5/11/2026) of MOTS-c (free base) and MOTS-c acetate for the 503A bulks list. States there is no USP/NF monograph and neither is a component of an FDA-approved drug; FDA did not identify clinical studies evaluating the proposed uses, found no published studies in which MOTS-c products were used in humans, and did not identify any clinical studies or human exposure data for MOTS-c via any route, so potential safety risks in humans are unknown. FAERS searches through March 9, 2025 retrieved no adverse-event reports. Nonclinical pharmacology is limited to in-vitro and rodent models without dose-response assessment, and FDA did not identify nonclinical toxicity studies. Raises immunogenicity concern for subcutaneous peptide injection. The nominated products were 5 mg and 10 mg for subcutaneous injection. Notes MOTS-c is listed as prohibited in Global DRO from the 2024 WADA Prohibited List. FDA proposed not adding MOTS-c or MOTS-c acetate to the 503A Bulks List.View study

Clinical trials

MOTS-c tested in people

1 registered study, 1 still enrolling.

1registered studies
1recruiting now
0phase 3 or 4
0with published results

By phase

Phase 21

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug1
Records only0

About 120 people took part in the studies that actually administered MOTS-c. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.

Most recent

  • NCT07505745Phase 2Recruiting120 enrolled

    MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity

    Hudson Biotech

See all 1 trial for MOTS-c

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when MOTS-c is named as an intervention; studies that only mention it in passing are not.

Questions

Frequently asked about MOTS-c

Is MOTS-c actually an 'exercise mimetic'?

Yes and no. MOTS-c activates many of the same pathways that exercise does—particularly AMPK and PGC-1α—which is why researchers call it an exercise mimetic [3][5]. Studies show it can prevent obesity and insulin resistance even without exercise [1]. However, it's not a complete replacement for physical activity, which has many benefits beyond metabolism. Think of MOTS-c as amplifying or supporting the benefits of exercise, not replacing it.

Will MOTS-c help me lose weight?

Animal studies show impressive prevention of diet-induced obesity, and MOTS-c's metabolic effects should theoretically support weight management [1]. However, human data is still limited. It's best viewed as a metabolic optimizer that may make your diet and exercise efforts more effective, rather than a standalone weight loss solution. Lifestyle factors remain essential.

Why haven't I heard of MOTS-c before?

MOTS-c was only discovered in 2015, making it one of the newest peptides in the longevity space [1]. It's part of a growing class called mitochondrial-derived peptides (MDPs) that researchers are just beginning to understand [2]. Scientific interest is rapidly growing, but clinical trials take time. You're essentially on the cutting edge of metabolic research.

Does MOTS-c naturally decline with age?

Yes, circulating MOTS-c levels decrease as we get older, which may contribute to age-related metabolic dysfunction [7]. This decline correlates with reduced insulin sensitivity, increased obesity risk, and decreased muscle function. Supplementing with MOTS-c may help restore more youthful metabolic signaling.

Can I take MOTS-c if I'm diabetic?

MOTS-c shows promising effects on insulin sensitivity, [1][2] but if you're diabetic and taking glucose-lowering medications, combining them with MOTS-c could cause dangerous hypoglycemia. Never start MOTS-c without consulting your doctor first, and be prepared to adjust your diabetes medications under medical supervision if you do use it.

How does MOTS-c compare to metformin?

Both activate AMPK and improve metabolic function, but through different mechanisms. Metformin works primarily in the liver and has decades of human data [9]. MOTS-c appears to work more directly on muscle and represents a newer, more targeted approach [1]. Some researchers suggest they could be complementary, as they target the same pathway from different angles.

What's the best time to take MOTS-c?

Morning dosing aligns best with your body's natural metabolic rhythms, when AMPK activity and insulin sensitivity are typically higher. Some users prefer taking it before or after morning exercise to potentially amplify the metabolic signaling from their workout.

Is MOTS-c FDA approved?

No, MOTS-c is not FDA approved. [10] It's classified as a research compound and is only available for research purposes. While the safety data from animal studies is encouraging, [8] large-scale human clinical trials have not been completed. [10] Always work with a knowledgeable healthcare provider if you're considering research compounds.

Further reading

MOTS-c history & related research

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for MOTS-c, on one page.

Medical disclaimer

MOTS-c is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026